Endra Life Sciences Inc (NDRA)

$0.21

Market is closed - opens 7 PM, 15 Oct 2024

Performance

  • $0.20
    $0.21
    $0.21
    downward going graph

    2.95%

    Downside

    Day's Volatility :2.95%

    Upside

    0.0%

    downward going graph
  • $0.18
    $139.50
    $0.21
    downward going graph

    13.62%

    Downside

    52 Weeks Volatility :99.87%

    Upside

    99.85%

    downward going graph

Returns

PeriodEndra Life Sciences IncIndex (Russel 2000)
3 Months
-95.41%
0.0%
6 Months
-98.4%
0.0%
1 Year
-99.6%
0.0%
3 Years
-99.99%
-22.2%

Highlights

Market Capitalization
3.9M
Book Value
$6.21
Earnings Per Share (EPS)
-32.0
PEG Ratio
0.0
Wall Street Target Price
10.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-60.94%
Return On Equity TTM
-120.13%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-9.5M
Diluted Eps TTM
-32.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-11.08
EPS Estimate Next Year
-8.91
EPS Estimate Current Quarter
-0.07
EPS Estimate Next Quarter
-0.04

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Endra Life Sciences Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 4661.9%

Current $0.21
Target $10.00

Technicals Summary

Sell

Neutral

Buy

Endra Life Sciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Endra Life Sciences Inc
Endra Life Sciences Inc
-4.55%
-98.4%
-99.6%
-99.99%
-99.98%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
-6.87%
-3.06%
10.88%
-24.37%
72.76%
Agilent Technologies Inc.
Agilent Technologies Inc.
3.98%
2.57%
28.99%
-5.75%
91.3%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
-2.81%
7.0%
22.18%
3.39%
110.0%
Danaher Corp.
Danaher Corp.
-2.06%
12.8%
28.45%
-10.02%
94.76%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
-4.23%
-0.82%
15.22%
-7.11%
56.64%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Endra Life Sciences Inc
Endra Life Sciences Inc
NA
NA
0.0
-11.08
-1.2
-0.61
NA
6.21
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
47.16
47.16
5.0
10.57
0.63
0.23
NA
19.16
Agilent Technologies Inc.
Agilent Technologies Inc.
29.96
29.96
3.08
5.24
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
37.03
37.03
2.21
21.73
0.14
0.05
0.0
124.17
Danaher Corp.
Danaher Corp.
49.78
49.78
2.63
7.59
0.08
0.04
0.0
68.92
Iqvia Holdings Inc.
Iqvia Holdings Inc.
29.77
29.77
1.14
11.2
0.23
0.05
NA
36.83
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Endra Life Sciences Inc
Endra Life Sciences Inc
Buy
$3.9M
-99.98%
NA
0.0%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$39.2B
72.76%
47.16
22.34%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$41.3B
91.3%
29.96
21.75%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$228.0B
110.0%
37.03
14.69%
Danaher Corp.
Danaher Corp.
Buy
$195.2B
94.76%
49.78
17.83%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$42.0B
56.64%
29.77
9.39%

Insights on Endra Life Sciences Inc

  • Vs A

    In the last 1 year, Agilent Technologies Inc. has given 30.1% return, outperforming this stock by 129.7%

  • Vs TMO

    In the last 3 years, Endra Life Sciences Inc has experienced a drawdown of -100.0%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 94.3%

Institutional Holdings

  • HRT FINANCIAL LLC

    0.04%
  • JANE STREET GROUP, LLC

    0.01%
  • Geode Capital Management, LLC

    0.01%
  • UBS Group AG

    0.01%

Company Information

endra life sciences is bringing new capabilities to ultrasound. our photo-acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. we’re proud to have a global installed base of leading institutions using our nexus-128 system, the only 3d imaging solution for imaging anatomy, physiology and labeled molecular targets. the nexus 128 is a preclinical photoacoustic computed tomography (ct) scanner for small animal imaging. the system is used for simple, fast, non-invasive quantification of physiological parameters such as tumor vasculature without ionizing radiation. the fully-3d imaging technology used by the nexus 128 provides increased sensitivity compared to slice-based scanners, and dynamic (4-d) photoacoustic ct scans allow for applications such as quantification of probe uptake. the nexus 128 is currently being used by top imaging laboratories around the globe.

Organization
Endra Life Sciences Inc
Employees
21
CEO
Mr. Alexander Y. Tokman
Industry
Health Technology

FAQs